Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2695 of 5804
-
Fiber fix? study tests if a simple supplement boosts arthritis Drug's power
Disease control CompletedFiber is the main source of energy for colonic bacteria and its consumption favorably modifies the composition of the microbiota in only a few days. Their fermentation in the colon releases short-chain fatty acids (SCFAs). Clostridiales contain many strains producing SCFAs. These…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pain education may get people moving again
Symptom relief Recruiting nowProposing ways to effectively counter chronic low back pain through non-drug intervention is a major public health issue due to the prevalence and health costs of this condition. The back school (BS) is based on spinal economics and a biomechanical model. A convergence of evidenc…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can a second injection fix penile curvature?
Disease control OngoingThe purpose of this study is to learn about the safety and side effects of intralesional collagenase clostridium histolyticum (CCH) injected into the Peyronies Disease (PD) plaque after receiving prior treatment with intralesional Platelet Rich Plasma (PRP) injections.
Phase: PHASE4 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Exercise and diet combo takes on fatty liver inflammation
Disease control Recruiting nowThe aim of the study is to estimate the effectiveness of two different exercise programs combined with the Mediterranean diet versus diet alone on inflammatory status in subjects aged 18-65 years with obesity (BMI\>30) and Non-Alcoholic Fatty Liver Disease (NAFLD) (CAP \>248 dB/m…
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Heated tobacco may cut harmful chemical exposure for smokers
Disease control CompletedThe purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smokers who completely switch to Ploom heated tobacco products (HTPs) compared to those who continue to smoke usual brand combustible c…
Phase: NA • Sponsor: Altria Client Services LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New combo aims to tame CAR T-Cell side effects in leukemia
Disease control OngoingTo assess the feasibility of oral dasatinib pulses (3 consecutive days per week) during the first month following infusion of brexucabtagene autoleucel (Tecartus) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New vibrating vest aims to make lung clearance easier for chronic lung patients
Symptom relief CompletedThis study will evaluate the effectiveness, safety, and tolerability of a novel wearable device, the ELECTROVEST, designed to improve airway clearance in patients with chronic respiratory diseases. The ELECTROVEST will integrate high-frequency chest wall oscillation (HFCWO) with …
Phase: NA • Sponsor: Hospitales Universitarios Virgen del Rocío • Aim: Symptom relief
Last updated Jun 26, 2026 18:17 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThe purpose of this study is to evaluate the safety and tolerability of RO7496353 in combination with a checkpoint inhibitor (CPI) with or without standard-of-care (SOC) chemotherapy in participants with locally advanced or metastatic solid tumors such as non-small cell lung canc…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New triple therapy shows promise for blood cancer patients
Disease control Recruiting nowThis phase Ib trial tests the safety and effectiveness of tafasitamab, acalabrutinib, and obinutuzumab in treating patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). CLL and SLL are types of cancer that develops from a spec…
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Battle of the bypass fixes: which procedure helps regain weight better?
Disease control OngoingThe goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (…
Phase: NA • Sponsor: Stephen Firkins • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Physio first: new model aims to ease hip and knee pain
Symptom relief OngoingThis is a cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.
Phase: NA • Sponsor: Queen's University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain-Training app aims to ease back pain without pills
Symptom relief Recruiting nowThe purpose of this study is to learn more about improving the quality of treatments for people who have chronic low back pain. Participants will complete interviews with Duke researchers at four different time points: the beginning of the study, at 3 months, at 6 months, and at …
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can dupixent calm mysterious skin flares?
Disease control CompletedThis research is studying a drug called dupilumab to learn about its safety and its effect as a treatment for participants with dermal hypersensitivity reaction. This study will help better understand why and how dermal hypersensitivity reaction occurs and how dupilumab might hel…
Phase: PHASE4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug HCB101 enters human trials for tough cancers
Disease control Recruiting nowThe purpose of this study is to find out whether IV injection of HCB101 is an effective treatment for different types of advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma and what side effects (unwanted effects) may occur in subjects aged 18 years old and abov…
Phase: PHASE1 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Free FIT kits at DMV aim to slash colorectal cancer in african americans
Prevention Recruiting nowAfrican Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 …
Phase: NA • Sponsor: University of Nebraska • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
New patch aims to stop bleeding faster in keyhole surgery
Disease control CompletedThis is a pre-market, prospective, randomized (1:1), multicenter, pivotal clinical investigation. The purpose of this investigation is to determine the clinical performance of GATT-Patch as compared with SURGICEL® Original for the management of minimal, mild, or moderate bleeding…
Phase: NA • Sponsor: GATT Technologies BV • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Smart stimulation: could a new tuning method end chronic pain?
Symptom relief Recruiting nowSpinal cord stimulation modulates the nervous system to effectively block pain signals originating from the back and legs. Spinal cord stimulation has been shown to improve chronic pain, improve quality of life, and reduce disability. Unfortunately, spinal cord stimulation has a …
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
AI could spare thousands from unnecessary scans for gallstones
Diagnosis Recruiting nowMachine learning predictive model can help in stratifying heterogenous intermediate likelihood group to reduce need for EUS or MRCP in selected subgroup of patients.
Sponsor: Asian Institute of Gastroenterology, India • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Liquid diet could shrink fatty liver without surgery
Disease control OngoingNon-alcoholic fatty liver disease (NAFLD) is a common complication of obesity which can progress to deadly complications like end-stage liver disease and hepatocellular carcinoma. In the wake of the obesity epidemic, NAFLD is becoming the main etiology of liver transplantation in…
Phase: NA • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Ear stimulation + exercise shows promise for Parkinson's symptoms
Symptom relief CompletedThe purpose of this study is to evaluate the combined effects of non-invasive neuromodulation (specifically transauricular Vagus Nerve Stimulation) with exercise interventions to improve physical function and quality of life in individuals with Parkinsons Disease.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC